|
|
Blood, 1 February 2004, Vol. 103, No. 3, pp. 941-947.
Prepublished online as a Blood First Edition Paper on October 2, 2003; DOI 10.1182/blood-2003-05-1505.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13
Derrick John Bowen, and
Peter William Collins
From the Department of Hematology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.
The hypothesis that increased ADAMTS13 (a disintegrin and metalloprotease with thrombospondin repeats) activity or increased susceptibility of von Willebrand factor (VWF) to proteolysis by ADAMTS13 may underlie type I von Willebrand disease (VWD) in some patients was investigated. Plasma from 4 patients with type I VWD was cryoprecipitated. ADAMTS13 activity in the VWF-poor cryodepleted fraction was assessed by incubation with purified VWF; susceptibility to proteolysis of the VWF in the VWF-rich cryoprecipitate was assessed by incubation with a normal, group O cryodepleted plasma. ADAMTS13 activity was similar in all 4 type I VWD cryodepleted plasmas and comparable to a normal control plasma. In contrast, the VWF of one patient showed increased susceptibility to proteolysis by ADAMTS13. Investigation of additional family members indicated that increased susceptibility was heritable, but it did not track uniquely with type I VWD. Sequence analysis of VWF exon 28 indicated that increased susceptibility to proteolysis tracked with the "G" allele of the A/G polymorphism at position 24/1282, encoding the amino acid polymorphism Tyr/Cys1584 ("G" = Cys1584). A prospective study of 200 individuals yielded 2 Tyr/Cys1584 heterozygotes; for both, plasma VWF showed increased susceptibility to proteolysis. The finding that an amino acid polymorphism in VWF may influence susceptibility to ADAMTS13 has potentially significant implications in diverse areas. (Blood. 2004;103:941-947)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
von Willebrand factor: polymorphism predicts prompt polypeptide proteolysis
- José A. López
Blood 2004 103: 754.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
J. A. Davies, P. W. Collins, L. S. Hathaway, and D. J. Bowen
Effect of von Willebrand factor Y/C1584 on in vivo protein level and function and interaction with ABO blood group
Blood,
April 1, 2007;
109(7):
2840 - 2846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Davies and D. J. Bowen
An association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13
Haematologica,
February 1, 2007;
92(2):
240 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. James, C. Notley, C. Hegadorn, J. Leggo, A. Tuttle, S. Tinlin, C. Brown, C. Andrews, A. Labelle, Y. Chirinian, et al.
The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study
Blood,
January 1, 2007;
109(1):
145 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Goodeve, J. Eikenboom, G. Castaman, F. Rodeghiero, A. B. Federici, J. Batlle, D. Meyer, C. Mazurier, J. Goudemand, R. Schneppenheim, et al.
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
Blood,
January 1, 2007;
109(1):
112 - 121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. A. Hassenpflug, U. Budde, T. Obser, D. Angerhaus, E. Drewke, S. Schneppenheim, and R. Schneppenheim
Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis
Blood,
March 15, 2006;
107(6):
2339 - 2345.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Plaimauer, J. Fuhrmann, G. Mohr, W. Wernhart, K. Bruno, S. Ferrari, C. Konetschny, G. Antoine, M. Rieger, and F. Scheiflinger
Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation
Blood,
January 1, 2006;
107(1):
118 - 125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. O'Donnell, T. A. J. McKinnon, J. T. B. Crawley, D. A. Lane, and M. A. Laffan
Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis
Blood,
September 15, 2005;
106(6):
1988 - 1991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Bowen
Increased susceptibility of von Willebrand factor to proteolysis by ADAMTS13: should the multimer profile be normal or type 2A?
Blood,
April 15, 2004;
103(8):
3246 - 3246.
[Full Text]
[PDF]
|
|
|
|
|
